Charles Schwab Bank »

Celldex Therapeutics shares owned by Charles Schwab Bank

Quarter-by-quarter ownership of Celldex Therapeutics shares owned by Charles Schwab Bank from 13F filings

Historical chart of Charles Schwab Bank investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Charles Schwab Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Charles Schwab Bank

Quarter filed Position value Share count Share price at filing
2013-03-31 $177k 15k 11.57